Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
10.1M
-
Shares change
-
+10.1M
-
Total reported value, excl. options
-
$195M
-
Value change
-
+$195M
-
Number of buys
-
60
-
Price
-
$19.34
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2021
60 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2021.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.1M shares
of 55M outstanding shares and own 18.31% of the company stock.
Largest 10 shareholders include Board of Trustees of The Leland Stanford Junior University (2.24M shares), Hudson Executive Capital LP (1.07M shares), Capital World Investors (700K shares), PRICE T ROWE ASSOCIATES INC /MD/ (501K shares), BlackRock Inc. (442K shares), VR Adviser, LLC (400K shares), FMR LLC (398K shares), VANGUARD GROUP INC (345K shares), FRANKLIN RESOURCES INC (320K shares), and AMERICAN CENTURY COMPANIES INC (306K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.